About Us

Ra Medical Systems was founded in 2002 by Dean Irwin and Melissa Burstein to design, develop, and commercialize excimer lasers for the treatment of dermatologic and cardiovascular diseases. Its flagship product, Pharos, launched in 2004 and revolutionized the dermatology world with its technological advancements and game-changing business model of affordable ownership with unlimited use.

Staying true to the values upon which the company was founded, Ra Medical Systems continued to be a private, clinically-oriented, scientifically-driven organization, focusing on self-funding its growth organically and sustainably. Maintaining profitability year after year by strategic cost management while exponentially growing revenue from Pharos laser sales in the US and internationally, profits were reinvested internally to fund the development of its cardiovascular laser and catheters.

In 2012, the first patients were treated with Ra Medical Systems’ cardiovascular DABRA catheter and laser system in a pilot study conducted outside the United States.

Over the past decade, Pharos has helped hundreds of thousands of patients triumph over difficult-to-treat skin diseases and gain more confidence in their appearance and themselves. Ra Medical Systems’ Pharos has transformed their lives.

Request a Call Back

Let us know how to get back to you.

Our Pledge To You

We, Ra Medical Systems, pledge to provide the highest quality, innovative technology that improves patients’ lives. We will do so with honesty and integrity, transparency in our actions, accountability for our products, and mindfulness of our responsibilities to our customers, their patients, and our shareholders.

A Legacy of Innovation

Ra Medical Systems was founded on three fundamental beliefs:

  • Excimer laser medicine could save and change lives for the better.
  • A totally new kind of company, built differently than those before it, could fulfill its potential.
  • The company must merge innovative science with pragmatic entrepreneurship, create a culture of smart, cost-effective decision making and personal accountability, and deliver better, safer, faster, and cheaper lasers and catheters.

This is the company we have built. This is the culture we have created. And this is the mission that drives us forward every day.

Leadership

    Latest Articles



    • Stat News (The Boston Globe) Interviews Ra Medical Systems EVP Melissa Burstein
      Melissa Burstein, EVP at Ra Medical Systems

      More female leaders will help drive innovation in the medtech and biotech industries I’m proud to be the executive vice president of a medical device company I co-founded 16 years ago. I love my industry and the innovative changes it creates that improve people’s lives around... Read More

       

    • FOX News Interviews Endovascular Surgeon Dr. Padidar on DABRA
      DABRA Endovascular Catheter and Excimer Laser for Peripheral Artery Disease Treatment (PAD)

      Known for his success with minimally invasive surgery solutions, endovascular surgeon Dr. Arash Padidar is a big proponent of the DABRA endovascular catheter and excimer laser. His success with DABRA won the attention of FOX 2 News, who interviewed Dr. Padidar. “DABRA vaporizes any plaque [arterial... Read More

       

    • BioSpace Covers Ra Medical Systems’ Appointment of Andrew Jackson as CFO

      The Perfect Fit for Ra Medical Published: Apr 19, 2018 CARLSBAD, Calif.--(BUSINESS WIRE)-- RA Medical Systems, Inc., manufacturers of laser-based solutions for the treatment of cardiovascular and dermatological diseases, announced today that the Company has appointed Andrew Jackson as its Chief Financial Officer, effective immediately. Mr... Read More

       

    • Ra Medical Systems Appoints Andrew Jackson as Chief Financial Officer
      Chief Financial Officer Andrew Jackson

      CARLSBAD, Calif. – April 19, 2018 – Ra Medical Systems, manufacturers of laser-based solutions for the treatment of cardiovascular and dermatological diseases, announced today that the Company has appointed Andrew Jackson as its Chief Financial Officer, effective immediately. Mr. Jackson has over 20 years of finance... Read More

       

    • Industry Welcomes Suspension of Device Tax

      HEALTH CARE: Tax Said to Hurt Staffing, R&D Efforts at Cos. San Diego — February 5, 2018 While San Diego’s medtech hub is cheering the recent suspension of a 2.3 percent excise tax on medical device makers, a full repeal remains the industry’s ultimate goal. A deal... Read More